ResMed Inc. vs Sprott Uranium Miners ETF — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Sprott Uranium Miners ETF trades at $50.32. The key difference: ResMed Inc. pays a 1.21% dividend while Sprott Uranium Miners ETF pays none. Which is the better fit depends on your goals.
| RMD | URNM | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $293.73 | $83.99 |
52-Week Low | $182.82 | $44.14 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →